SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-002237
Filing Date
2023-01-23
Accepted
2023-01-23 18:14:17
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1505
  Complete submission text file 0001493152-23-002237.txt   3081
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COMPASS 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address
Bisker-Leib Vered (Reporting) CIK: 0001814093 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36138 | Film No.: 23545469